Retatrutide vs Semaglutide: What Users Report
Retatrutide vs semaglutide: what users report. Confession counts, weight phrases, and side effects side by side. Not medical advice.
What is the difference between retatrutide and semaglutide?
Semaglutide is a GLP-1 peptide. Ozempic and Wegovy are brands of it. Retatrutide is a GLP-1, GIP, and glucagon peptide. It is a different molecule, and it is not an approved product.
Educational page. Anonymous reports, not medical advice, and not a dosing recommendation.
Retatrutide vs Semaglutide, side by side
Counts are phrase matches inside published confessions tagged with that peptide. A story tagged with both is in both columns. A higher number is more people using the phrase, not a result, and not a winner. The same method is written up on the Retatrutide side-effect report. That report counts retatrutide only.
| Retatrutide | Semaglutide | |
|---|---|---|
| Published confessions | 342 | 37 |
| Tagged with both | 16. Examples: #307, #449, #666, #757 | Same confessions |
| Hub | Retatrutide hub | Semaglutide hub |
| Data report | Retatrutide side-effect report | No separate report. The hub is the file. |
| Milligram figure in the text | 106. Not a dosing recommendation. | 5. Not a dosing recommendation. |
| Weight figure (lost, down, or dropped) | 46 (13.5%) | 4 (10.8%) |
| Weight-loss phrase | 32 (9.4%) | 6 (16.2%) |
| Appetite, hunger, or food noise | 33 (9.6%) | 4 (10.8%) |
| Nausea | 7 (2%) | 2 (5.4%) |
| Constipation | 4 (1.2%) | 1 (2.7%) |
| Vomiting | 3 (0.9%) | 2 (5.4%) |
| Heart rate or palpitations | 22 (6.4%) | 0 (0%) |
| Fatigue or exhaustion | 6 (1.8%) | 0 (0%) |
| Anxiety or panic | 9 (2.6%) | 1 (2.7%) |
| Hair shedding | 1 (0.3%) | 1 (2.7%) |
What users report
Head-to-head notes in this archive disagree with each other.
#449 describes eighteen pounds in ten weeks on retatrutide. The same confession says a brother who had done well on semaglutide felt almost no appetite suppression on retatrutide, gained ten pounds, and went back.
#757 describes a year on Ozempic, then three months on retatrutide, with less weight loss and more nausea. The confession names a milligram figure. Not a dosing recommendation.
#307 describes retatrutide as wired, and says that is not the sedated feeling they associate with semaglutide.
#666 describes blurry distance vision after increasing retatrutide, which they say did not happen on semaglutide. They also say an eye exam looked fine. That is the account, not a diagnosis.
Hubs: retatrutide and semaglutide. Retatrutide phrase counts are also on the side-effect report. Semaglutide has no separate data report. The hub is the file.
What this page will not say
It will not say retatrutide causes more weight loss, or that semaglutide is gentler. #449 contains both a loss on retatrutide and a gain after leaving semaglutide. One confession is not a direction.
It will not rank heart rate, nausea, or vision. The table is a phrase count. It is not a safety ranking, and it is not a dose. Not a dosing recommendation.
Related topics
data reports:
related peptides:
community guides:
More confessions from the archive
Community Q&A
- What is the difference between retatrutide and semaglutide?
- Semaglutide is a GLP-1 peptide. Ozempic and Wegovy are brands of it. Retatrutide is a GLP-1, GIP, and glucagon peptide, and it is not an approved product. Not the same molecule, and not a ranked pair.
- Retatrutide vs semaglutide: which do the reports prefer?
- They do not settle it. #757 describes less loss and more nausea on retatrutide after a year of Ozempic. #449 describes a personal loss on retatrutide and a family member who gained and went back to semaglutide. This page does not pick one.
- Are the doses on this page a recommendation?
- No. Not a dosing recommendation. #757 names an amount. The table counts confessions that include a milligram figure and does not repeat it as a dose.
- How many Retatrutide and Semaglutide confessions are counted?
- 342 published confessions are tagged Retatrutide. 37 are tagged Semaglutide. 16 are tagged with both, and those sit in both columns. A percentage is the share of that column that used a phrase. Silence is not recorded. In the side-effect rows, the most mentioned phrase on the Retatrutide side is heart rate or palpitations (22 of 342). On the Semaglutide side it is nausea (2 of 37). That is not a safety ranking.
- Does a higher side-effect count mean one is riskier?
- No. This archive does not say. A phrase count is the share of published confessions that used a word. The files are different sizes, many confessions name more than one peptide, and nobody was asked a standard list of effects. This is not a safety ranking.
Sources
Anonymous first-hand reports plus sourced context — educational only, not medical advice. Editorial policy & corrections.